Our authored documents, platform science, neo-organ application, and other clinical information are detailed in our publications section below. If you have any questions about our papers, please contact us.
Design and Analysis Methods for Developing Personalized Treatment Rules
Design and Analysis Methods for Developing Personalized Treatment Rules
Emily L. Butler and Michael R. Kosorok
University of North Carolina
Chapel Hill, NC
SAFETY AND FEASIBILITY OF A NOVEL PERCUTANEOUS LOCOREGIONAL INJECTION TECHNIQUE OF RENAL CELLULAR THERAPY FOR CHRONIC KIDNEY DISEASE OF DIABETES
Hyeon Yu , Paul D. Sonntag , Peter R. Bream , Michael P. Lazarowicz, Francis S. Nowakowski, Gregory J. Woodhead, Charles T. Hennemeyer, Ryan D. Muller, Rakesh Navuluri, Elaine M. Caoili, Aaron C. Eifler, Brandon S. Tominna and Joseph M. Stavas
Economic Modeling of Chronic Kidney Disease (CKD) Using Estimated Glomerular Filtration Rate (eGFR) Slope: Effect on CKD Modeling of Acceptance of a New Surrogate Outcome
Marczell K; Gal P; Benedict Á; Stavas JM; Coulston J; Caro JJ
Protocol and Baseline Data on Renal Autologous Cell Therapy Injection in Adults with Chronic Kidney Disease Secondary to Congenital Anomalies of the Kidney and Urinary Tract
Joseph Stavas, Maria Diaz-Gonzalez de Ferris, Ashley Johns, Deepak Jain, Tim Bertram
RENAL AUTOLOGOUS CELL Therapy/NEO-KIDNEY AUGMENT TM (REACT/NKA): PHASE II STUDY OF REACT/NKA IMPLANTATION IN Type 2 DIABETES WITH CHRONIC KIDNEY DISEASE
Joseph Stavas, Tim Bertram, Ashley Johns, Deepak Jain, David Gerber, Prabir Roy-Chaudhury, George Bakris
RENAL AUTOLOGOUS CELL THERAPY/NEO-KIDNEY AUGMENT TM (REACT/NKA): PHASE II STUDY OF REACT/NKA IMPANTATION IN TYPE 2 DIABETES WITH PRE-STAGE 5 CHRORIC KIDNEY DISEASE
Joseph Stavas, Tim Bertram, Deepak Jain, Ashely Johns, David Gerber, Prabir Roy-Chaudhury , George Bakris
IMPLANTATION OF AUTOLOGOUS SELECTED RENAL CELLS IN DIABETIC CHRONIC KIDNEY DISEASE STAGES 3 AND 4—CLINICAL EXPERIENCE OF A “FIRST IN HUMAN” STUDY
Peter Stenvinkel, Jonas Wadström, Tim Bertram, Randal Detwiler, David Gerber,
Torkel B. Brismar, Pontus Blomberg and Torbjörn Lundgren
A POPULATION OF SELECTED RENAL CELLS AUGMENTS RENAL FUNCTION AND EXTENDS SURVIVAL IN THE ZSF1 MODEL OF PROGRESSIVE DIABETIC NEPHROPATHY
Rusty Kelley, Andrew Bruce, Tom Spencer, Eric Werdin, Roger Ilagan, Sumana Choudhury, Elias Rivera, Shay Wallace, Kelly Guthrie, Manuel Jayo, Fengfeng Xu, Anjali N. Rao, Benjamin D. Humphreys, Sharon Presnell and Tim Bertram
MOLECULAR CHARACTERIZATION OF THE REGENERATIVE RESPONSE INDUCED BY INTRARENAL TRANSPLANTATION OF SELECTED RENAL CELLS IN A RODENT MODEL OF CHRONIC KIDNEY DISEASE
Genheimer, W.G., Ilagan R.M., Spencer T., Kelley R., Werdin E., Choudhury S., Jain D., Ludlow J.W., Basu J. (2012). Molecular Characterization of the Regenerative Response Induced by Intrarenal Transplantation of Selected Renal Cells in a Rodent Model of Chronic Kidney Disease. Cells Tissues Organs 2012;196:374–384
FUNCTIONAL EVALUATION OF PRIMARY RENAL CELL/BIOMATERIAL NEO-KIDNEY AUGMENT PROTOTYPES FOR RENAL TISSUE ENGINEERING
Basu J., Genheimer C.W., Rivera E.A., Payne R., Mihalko K., Guthrie K., Bruce A.T., Robbins N., McCoy D., Sangha N., Ilagan R., Knight T., Spencer T., Wagner B.J., Jayo M.J., Jain D., Ludlow J.W., Halberstadt C. (2011, March). Functional evaluation of primary renal cell/biomaterial Neo-Kidney Augment prototypes for renal tissue engineering Cell Transplant. 2011 Mar 24. doi: 10.3727/096368911X566172.
A TUBULAR CELL-ENRICHED SUBPOPULATION OF PRIMARY RENAL CELLS IMPROVES SURVIVAL AND AUGMENTS KIDNEY FUNCTION IN A RODENT MODEL OF CHRONIC KIDNEY DISEASE.
Kelley R., Werdin E.S., Bruce A.T., Choudhury S., Wallace S.M., Ilagan R.M., Cox B.R., Tatsumi-Ficht P., Rivera E.A., Spencer T., Rapoport H.S., Wagner B.J., Guthrie K., Jayo M.J., Bertram T.A., Presnell S.C. (2010, September 8). A tubular cell-enriched subpopulation of primary renal cells improves survival and augments kidney function in a rodent model of chronic kidney disease. Am J Physiol Renal Physiol (September 8, 2010). doi:10.1152/ajprenal.00221.2010
ISOLATION, CHARACTERIZATION, AND EXPANSION (ICE) METHODS FOR DEFINED PRIMARY RENAL CELL POPULATIONS FROM RODENT, CANINE, AND HUMAN NORMAL AND DISEASED KIDNEYS.
Presnell S.C., Bruce A.T., Wallace S.M., Choudhury S., Genheimer C., Cox B., Guthrie K.I., Werdin E.S., Tatsumi-Ficht P., Ilagan R., Kelley R.W., Rivera E.A., Ludlow J.W., Wagner B.J., Jayo M.J., Bertram T. (2010, September 16) Isolation, Characterization, and Expansion (ICE) Methods for Defined Primary Renal Cell Populations from Rodent, Canine, and Human Normal and Diseased Kidneys.Tissue Eng Part C Methods. 2010 Sep 16.
DEVELOPMENT OF A NEO-KIDNEY AUGMENT PRODUCT INTENDED TO PREVENT OR DELAY THE NEED FOR DIALYSIS OR TRANSPLANTATION IN CKD PATIENTS
Jain, D., Payne, R., Halberstadt, C., Knight, T., Robbins, N., Rivera E., Kelley R., Ludlow, J., Guthrie, K., Bertram, T.A. (2012, November). Development of a Neo-Kidney Augment Product Intended to Prevent or Delay the Need for Dialysis or Transplantation in CKD Patients. Presented at the American Society of Nephrology Meeting, San Diego, CA Oct 30-Nov 4, 2012.
CELL-BASED THERAPEUTIC PRODUCTS: POTENCY ASSAY DEVELOPMENT AND APPLICATION
Basu J., Ludlow J.W. (2014 September). Cell-based therapeutic products: potency assay development and application. Regen. Med. (2014) 9(4), 497-512.
DEVELOPMENTAL ENGINEERING THE KIDNEY: LEVERAGING PRINCIPLES OF MORPHOGENESIS FOR RENAL REGENERATION
Basu J., Ludlow J.W. (2012). Developmental Engineering the Kidney: Leveraging Principles of Morphogenesis for Renal Regeneration. Birth Defects Research (Part C) 96:30–38 (2012)
A NEO-KIDNEY AUGMENT PRODUCT FOR KIDNEY REGENERATION IN A LARGE ANIMAL MODEL OF CHRONIC KIDNEY DISEASE.
Jain D., Payne R., Basu J., Halberstadt C.R., Knight T., Robbins, N. McCoy D., Riveria E., Genheimer C., Sangha N., Bruce A., Kelley, R., Bertram T.A. (2012, June). A Neo-Kidney Augment Product for Kidney Regeneration in a Large Animal Model of Chronic Kidney Disease. Presented at the 18th Annual International Society for Cellular Therapy (ISCT) Meeting, Seattle WA, June 5-8, 2012
ATHYMIC RAT REDUCED KIDNEY MASS MODEL: A SCREENING TOOL TO IDENTIFY HUMAN‐SOURCED CELL‐BASED THERAPEUTIC PROTOTYPES FOR REGENERATION AND STABILIZATION OF KIDNEY FUNCTION
Guthrie K.I., Rivera E., Sangha N., Bertram T.A., Jain D. and Basu J. (2014, November). Athymic Rat Reduced Kidney Mass Model: A Screening Tool to Identify Human-Sourced Cell-Based Therapeutic Prototypes for Regeneration and Stabilization of Kidney Function. Presented at American Society of Nephrology, Philadelphia, PA; November, 2014
ATTENUATION OF DISEASE PROGRESSION WITH SELECTED RENAL CELL POPULATIONS IN ANIMAL MODELS OF CHRONIC KIDNEY DISEASE
Helena Genberg, Torbjorn Lundgren, Andrew Bruce, Kelly Guthrie, Namrata Sangha, Joydeep Basu Elias Rivera, Thomas Spencer, Tim Bertram and Deepak Jain (2013, September). Attenuation of Disease Progression with Selected Renal Cell Populations in Animal Models of Chronic Kidney Disease. Presented at: ISN Forefronts Symposia – Stem Cells and Kidney Regeneration Florence Italy Sep 12-15 2013
BIOACTIVE RENAL CELLS AUGMENT KIDNEY FUNCTION IN A RODENT MODEL OF CHRONIC KIDNEY DISEASE
Kelley R., Werdin E.S., Bruce A.T., Choudhury S., Wallace S.M., Tatsumi-Ficht P., Rivera E.A., Spencer T., Rapoport H.S., Ilagan R.M., Wagner B.J., Jayo M.J., Bertram T.A., Presnell S.C. (2010, May 24). Bioactive Renal Cells Augment Kidney Function In A Rodent Model Of Chronic Kidney Disease.Podium Presentation at 16th Annual Meeting of The International Society For Cellular Therapy, Philadelphia, PA May 23-26, 2010.
BIOACTIVE RENAL CELLS AUGMENT RENAL FUNCTION IN THE ZSF1 MODEL OF DIABETIC NEPHROPATHY.
Kelley R.W., Werdin E.S., Bruce A.T., Wallace S.M., Jayo M.J., Bertram T.A. and Presnell S.C. (2010, December). Bioactive Renal Cells Augment Renal Function in the ZSF1 model of Diabetic Nephropathy. Oral Presentation given at Tissue Engineering and Regenerative Medicine International Society (TERMIS) – North America Annual Conference, December 5 – 8, 2010.
BIORESPONSE OF A CELL/ALGINATE HYDROGEL COMPOSITE IN MAMMALIAN KIDNEY
Knight T., Payne, R., Rivera E., Basu J., Robbins, N., McCoy D., Halberstadt, C., Jayo M. Jain D. (2013, November). Bioresponse of a Cell/Alginate Hydrogel Composite in Mammalian Kidney. Presented at Tissue Engineering and Regenerative Medicine International Society (TERMIS) – North America, Atlanta Nov 10-13, 2013.
BIORESPONSE OF A RODENT HEMI-NEPHRECTOMY MODEL TO IMPLANTATION OF NEOKIDNEY AUGMENT PROTOTYPES COMPOSED OF SELECTED RENAL CELLS AND BIOMATERIALS
Basu J., Payne R., Rivera E., Robbins N., McCoy D., Knight T., Sangha N., Guthrie K., Spencer T., Genheimer C., Jain D., Ludlow J.W. and Halberstadt C. (October 2011). Bioresponse of a Rodent Hemi-Nephrectomy Model to Implantation of Neo- Kidney Augment Prototypes Composed of Selected Renal Cells and Biomaterials. Poster presentation at Joint Congress 2011 Cell Transplant Society / International Xenotransplantation Association, October 23 – 26, Miami, Florida.
BIORESPONSE OF MAMMALIAN KIDNEY TO IMPLANTATION OF POLYMERIC MATERIALS
Payne R., Knight T., Basu J., Rivera E., Robbins N., McCoy D., Jayo M., Halberstadt C., Jain D. (2011, April). Bioresponse of Mammalian Kidney to Implantation of Polymeric Materials Poster presented at 2011 Society for Biomaterials Annual Meeting & Exposition, April 13-16, 2011 in Orlando, Florida.
CATALYZING KIDNEY REGENERATION USING SELECTED RENAL CELLS AND BIOMATERIALS IN A NEO-KIDNEY AUGMENT PRODUCT.
Jain D., Payne R. et al (2011, March). Catalyzing Kidney Regeneration using Selected Renal Cells and Biomaterials in a Neo-Kidney Augment Product. Oral Presentation given at Tissue Engineering meeting, Hilton Head, NC March 2011.
CELL TRANSPLANT APPROACHES TO KIDNEY REGENERATION.
Cell Transplant Approaches to Kidney Regeneration. (2010, October). Podium presentation at American Society of Transplantation-Annual Scientific Exchange (AST-ASE), Orlando, FL October 21-24, 2010.
CHARACTERIZATION OF PRIMARY ADULT CANINE RENAL CELLS (CRC) IN A THREE-DIMENSIONAL (3D) CULTURE SYSTEM PERMISSIVE FOR EX VIVO NEPHROGENESIS
Ilagan RM, Guthrie K, Sangha N, Quinlan S, Delo O’Reilly D, Jain D, Bertram TA, Presnell SC, and Ludlow JW (2009, July 29-31).Characterization of primary adult canine renal cells (CRC) in a three-dimensional (3D) culture system permissive for ex vivo nephrogenesis.Poster presented at the 2009 KIDSTEM International Conference, Edinburgh, Scotland.
DEVELOPMENT OF TISSUE ENGINEERED REGENERATIVE MEDICINE PRODUCTS USING SELECTED AUTOLOGOUS CELLS AND BIOMATERIALS
Jain D., Jayo M.J., Bertram T.A. (2011, May). Development of Tissue Engineered Regenerative Medicine Products using Selected Autologous Cells and Biomaterials. Presented at The International Society for Cellular Therapy 17th Annual Meeting, Rotterdam, The Netherlands, May 18-21, 2011.
DEVELOPMENTS IN TISSUE ENGINEERED AND REGENERATIVE MEDICINE PRODUCTS
Joydeep Basu and John W. Ludlow. Developments in tissue engineered and regenerative medicine products. (2014)
DISCOVERY AND DEVELOPMENT OF REGENERATIVE MEDICINE PRODUCTS COMPRISED OF AUTOLOGOUS CELLS AND BIOMATERIALS.
Presnell S.C., Jayo M.J., Jain D., & Bertram T.A. Discovery and Development of Regenerative Medicine Products Comprised of Autologous Cells and Biomaterials.Podium presentation at International Society for Cellular Therapy (ISCT) 2nd Annual Symposium on Stem Cell Translation, San Francisco, CA on September 27-28, 2010..
DYNAMIC BIODISTRIBUTION OF THERAPEUTICALLY BIOACTIVE SELECTED RENAL CELLS IN LARGE ANIMAL PRE-CLINICAL MODEL
Basu J., Sangha N., Bertram, T.A., Jain D. (2014, June). Dynamic Bio-distribution of Therapeutically Bioactive Selected Regenerative Renal Cells in Large Animal Pre-Clinical Model. Presented at the 12th Annual Meeting of the International Society for Stem Cell Research, Vancouver, CANADA, June 2014.
ENHANCED RENAL CELL FUNCTION IN DYNAMIC 3D CULTURE SYSTEM
Kelley, R., Bruce, A., Wallace, S., Choudhury, S., Tatsumi, P., Das, A., Riveras, E., & Presnell, S. (2008, September 17-19). Enhanced renal cell function in dynamic 3D culture system. Poster presented at the KIDSTEM International Conference, Liverpool, England.
ENHANCING TISSUE ENGINEERING AND REGENERATIVE MEDICINE PRODUCT COMMERCIALIZATION: THE ROLE OF SCIENCE IN REGULATORY DECISION-MAKING FOR THE TE/RM PRODUCT DEVELOPMENT
Enhancing Tissue Engineering and Regenerative Medicine Product Commercialization: The Role of Science in Regulatory Decision-Making for the TERM Product Development
Timothy A. Bertram, DVM, PhD, DACVP,1,* Peter C. Johnson, MD,2,* Bill J. Tawil, PhD,3,*
Mark Van Dyke, PhD,4,* and Kiki B. Hellman, PhD5,*
EX VIVO CULTURE AND SEPARATION OF FUNCTIONAL RENAL CELLS
Andrew T. Bruce , Kelly I. Guthrie , and Rusty Kelley. Ex Vivo Culture and Separation of Functional Renal Cells (2012)
FABRICATION OF CHEMICALLY CROSSLINKED GELATIN MICROSPHERES WITH TUNABLE DEGRADATION PROFILES
Serban M.A., Knight T., Payne R., Basu J., Rivera E.A., Robbins N., McCoy D., Halberstadt C., Jain D., Bertram T.A. (2011, April). Fabrication of Chemically Crosslinked Gelatin Microspheres with Tunable Degradation Profiles Poster presented at 2011 Society for Biomaterials Annual Meeting & Exposition, April 13-16, 2011 in Orlando, Florida.
FORMULATION OF SELECTED RENAL CELLS FOR IMPLANTATION INTO A KIDNEY
Craig Halberstadt , Neil Robbins , Darell W. McCoy , Kelly I. Guthrie, Andrew T. Bruce , Toyin A. Knight , and Richard G. Payne. Formulation of Selected Renal Cells for Implantation into a Kidney (2013)
HOW REGENERATIVE MEDICINE STAKEHOLDERS ADAPT TO EVER-CHANGING TECHNOLOGY AND REGULATORY CHALLENGES? SNAPSHOTS FROM THE WORLD TERMIS INDUSTRY SYMPOSIUM
How Regenerative Medicine Stakeholders Adaptto Ever-Changing Technology and Regulatory Challenges?Snapshots from the World TERMIS Industry Symposium (September 10, 2015, Boston) Yves Bayon, PhD,1 Mark Van Dyke, PhD,2 Robert Buelher, PhD,3 Ross Tubo, PhD,4 Tim Bertram, PhD,5Bernard Malfroy-Camine, PhD,6 Michelle Rathman, PhD,7 and Vincent Ronfard, PhD8
HYPOXIC EXPOSURE OF CULTURED HUMAN RENAL CELLS INDUCES MEDIATORS OF CELL MIGRATION AND ATTACHMENT AND FACILITATES THE REPAIR OF TUBULAR CELL MONOLAYERS IN VITRO
Bruce A., Watts B., Cox B., Genheimer C., Werdin E., Guthrie K., Ilagan R., Kelley R., Presnell S., Wallace S., Choudhury S. (2011, April). Hypoxic Exposure of Cultured Human Renal Cells Induces Mediators of Cell Migration and Attachment and Facilitates the Repair of Tubular Cell Monolayers in vitro. Podium presentation given at Experimental Biology Meeting in Washington, DC, April 10, 2011.
INTRA-RENAL TRANSPLANTATION OF BIOACTIVE RENAL CELLS PRESERVES RENAL FUNCTIONS AND EXTENDS SURVIVAL IN THE ZSF1 MODEL OF PROGRESSIVE DIABETIC NEPHROPATHY
Kelley R., Spencer T., Werdin E., Bruce A., Ilagan R., Wallace S., Watts B., Choudhury S., Cox B., Guthrie K., Jayo M., Bertram T., Presnell S. (June 2011). Intra-renal Transplantation of Bioactive Renal Cells Preserves Renal Functions and Extends Survival in the ZSF1 model of Progressive Diabetic Nephropathy. Poster presentation at 71st Scientific Sessions of American Diabetes Association, June 24 – 27, 2011 in San Diego, CA.
IN VIVO EVALUATION OF BIOMATERIALS IN MAMMALIAN KIDNEY.
Basu J., Payne R., Rivera E., Robbins N., McCoy D., Knight T., Jayo M.J., Jain D., Halberstadt C.R. (2010, December). In vivo Evaluation of Biomaterials in Mammalian Kidney. Poster Presentation given at Tissue Engineering and Regenerative Medicine International Society (TERMIS) – North America Annual Conference, December 5 – 8, 2010.
ISOLATION AND CHARACTERIZATION OF BIORESPONSIVE RENAL CELLS FROM HUMAN AND LARGE MAMMAL WITH CHRONIC RENAL FAILURE.
Presnell S.C., Bruce A., Wallace S.M., Choudhury S., Kelley R., Tatsumi P., Werdin E., Rivera E., Merricks E., Nichols T.C., Jennette J.C., Jayo M.J., Bertram T.A. (2009, April 18). Isolation and characterization of bioresponsive renal cells from human and large mammal with chronic renal failure. Poster presented at the Experimental Biology Meeting, held in New Orleans, LA, April 18-22, 2009.
ISOLATION AND PROPAGATION OF THERAPEUTICALLY-RELEVANT CELLS, INCLUDING EPO-PRODUCING CELLS, FROM SEVERELY DISEASED KIDNEYS TRANSLATES ACROSS RODENTS, LARGE MAMMALS AND HUMANS.
Kelley RW, Werdin ES, Bruce AT, Choudhury S, Wallace SM, Tatsumi-Ficht P, Rivera EA, Jayo MJ, Bertram TA, and Presnell SC (2009, July 29-31). Isolation and propagation of therapeutically-relevant cells, including Epo-producing cells, from severely diseased kidneys translates across rodents, large mammals and humans.Poster presented at the 2009 KIDSTEM International Conference, Edinburgh, Scotland.
MAMMALIAN KIDNEY NEPHROGENIC RESPONSE TO PRIMARY RENAL CELL/BIOMATERIAL-BASED NEO-KIDNEY AUGMENT™ PROTOTYPE.
Basu J., Rivera E., Genheimer C.W., Robbins N., Payne R., McCoy D., Guthrie K.I., Sangha N., Knight T., Jayo M., Ludlow J.W., Jain D., and Halberstadt C.R.. (2010, December). Mammalian Kidney Nephrogenic Response to Primary Renal Cell/Biomaterial-based Neo-Kidney Augment™ Prototype. Poster Presentation given at Tissue Engineering and Regenerative Medicine International Society (TERMIS) – North America Annual Conference, December 5 – 8, 2010.
MULTIVARIATE ANALYSIS OF PRECLINICAL DATA FROM THE NEO-KIDNEY AUGMENT
Spencer T., Kelley R., Werdin E., Bruce A., Jain D. (2011, December) Multivariate Analysis of Preclinical Data from the Neo-Kidney Augment.. Podium presentation given at Tissue Engineering and Regenerative Medicine International Society (TERMIS) – North America Annual Conference, December 11-14, 2010, Houston, Texas.
ORGAN SPECIFIC REGENERATIVE MARKERS IN PERI-ORGAN ADIPOSE: KIDNEY
Basu J., Genheimer C., Sangha N., Quinlan S., Guthrie K., Kelley R., Ilagan R., Jain D., Bertram T.A. and Ludlow J.W. (June 2011). Organ Specific Regenerative Markers in Peri-Organ Adipose: Kidney. Poster presentation to the 9th Annual meeting of International Society of Stem Cell Research (ISSCR), Toronto, Ontario Canada, June 15 – 18, 2011.
PARACRINE FACTORS DERIVED FROM BIOACTIVE KIDNEY CELLS PROVIDE ANTI-FIBROTIC SIGNALS IN VITRO AND MAY MEDIATE REGENERATIVE OUTCOMES IN VIVO.
Choudhury S., Bruce A.T., Kelley R.W., Cox B.R., Werdin E.S., Watts B., Presnell S.C., and Ilagan R.M. (2010, December). Paracrine Factors Derived from Bioactive Kidney Cells Provide Anti-fibrotic Signals in vitro and may Mediate Regenerative Outcomes in vivo. Poster Presentation given at Tissue Engineering and Regenerative Medicine International Society (TERMIS) – North America Annual Conference, December 5 – 8, 2010.
PHENOTYPIC ANALYSIS OF BIOACTIVE CELLS FOR APPLICATION IN REGENERATIVE MEDICINE
Teresa Bora Burnette and Andrew T. Bruce. Phenotypic Analysis of Bioactive Cells for Application in Regenerative Medicine (2013)
PREPARATION AND EVALUATION OF NATURAL SCAFFOLD MATERIALS FOR KIDNEY REGENERATIVE APPLICATIONS
Monica A. Serban , Toyin A. Knight , and Richard G. Payne. Preparation and Evaluation of Natural Scaffold Materials for Kidney Regenerative Applications (2013)
QUANTITATIVE EX VIVO CHARACTERIZATION OF HUMAN RENAL CELL POPULATION DYNAMICS VIA HIGH-CONTENT IMAGE-BASED ANALYSIS (HCA).
Wallace S.M., Bruce A.T., Choudhury S., Tatsumi-Ficht P., Cox B.R., Wagner B.J., Kelley R., Presnell S.C. (2010, May 26). Quantitative Ex Vivo Characterization Of Human Renal Cell Population Dynamics Via High-Content Image-Based Analysis (HCA). Podium Presentation at 16th Annual Meeting of The International Society For Cellular Therapy, Philadelphia, PA May 23-26, 2010.
REGENERATING KIDNEY TISSUE WITH A NEO-KIDNEY AUGMENT IMPLANT CONTAINING SELECTED RENAL CELLS AND NATURAL BIOMATERIAL
Jain D., Ludlow J.W., Halberstadt C.R., Payne R., Guthrie K., Genheimer C., Spencer T., Riveria E., Garg N., Bertram T.A. (2012, September). Regenerating Kidney Tissue with a Neo-Kidney Augment Implant Containing Selected Renal cells and Natural Biomaterial. Presented at the 3rd TERMIS World Congress 2012, Vienna, Austria, Sep 5-8, 2012.
SECRETED FACTORS FROM BIOACTIVE KIDNEY CELLS ATTENUATE NF-KAPPA-B.
Ilagan R.M., Guthrie K.I., Cox B.R., Choudhury S., Bruce A.T., Watts B., O’Reilly D.D., Tang C., Genheimer C.W., Werdin E.S., Kelley R.W., and Presnell, S.C. (2010, December). Secreted Factors from Bioactive Kidney Cells Attenuate NF-kappa-B. Poster Presentation given at Tissue Engineering and Regenerative Medicine International Society (TERMIS) – North America Annual Conference, December 5 – 8, 2010.
SELECTED REGENERATIVE RENAL CELLS COMBINED WITH BIORESORBABLE NATURAL BIOMATERIALS CATALYZE IN VIVO KIDNEY TISSUE REGENERATION.
Jain D., Basu J., Halberstadt C., Rivera E., Knight T., Payne R., Robbins N., McCoy D., Guthrie K., Sangha N., Genheimer C., Ludlow J., and Bertram T. (2011, December) Selected Regenerative Renal Cells combined with Bioresorbable Natural Biomaterials catalyze in vivo Kidney Tissue Regeneration. Regenerative Medicine International Society (TERMIS) – North America Annual Conference, December 11-14, 2010, Houston, Texas.
SELECTED RENAL CELLS MODULATE DISEASE PROGRESSION IN RODENT MODELS OF CHRONIC KIDNEY DISEASE
Selected renal cells modulate disease progression in rodent models of chronic kidney disease
Andrew T Bruce1,2, Roger M Ilagan1,2, Kelly I Guthrie1,2,
Elias Rivera2,3, Sumana Choudhury2,4, Namrata Sangha2,5, Thomas Spencer2,6, Timothy A Bertram2,6, Deepak Jain2,6, Russell W Kelley2,7 & Joydeep Basu*,2,6
STEM AND PROGENITOR MARKER EXPRESSION AS A PREDICTOR OF RENAL REGENERATION IN 5/6 NEPHRECTOMIZED RATS TREATED WITH THERAPEUTICALLY BIO-ACTIVE PRIMARY RENAL CELL SUB-POPULATIONS.
Stem and Progenitor Marker Expression as a Predictor of Renal Regeneration in 5/6 Nephrectomized Rats Treated with Therapeutically Bio-Active Primary Renal Cell Sub-Populations. Poster presented at World Stem Cell Summit, held October 4-6, 2010 in Detroit, MI.
TISSUE ENGINEERING AND REGENERATIVE MEDICINE: ROLE OF TOXICOLOGIC PATHOLOGISTS FOR AN EMERGING MEDICAL TECHNOLOGY.
Jayo, M. J., Watson, D. D., Wagner, B. J., & Bertram, T. A. (2008). Tissue engineering and regenerative medicine: role of toxicologic pathologists for an emerging medical technology. Toxicol Pathol, 36(1), 92-96.
TISSUE ENGINEERING OF TUBULAR AND SOLID ORGANS: AN INDUSTRY PERSPECTIVE
Joydeep Basu and John W. Ludlow. Tissue Engineering of Tubular and Solid Organs: An Industry Perspective
Bioprocess Research and Assay Development, Tengion Inc., North Carolina, USA